Epilepsy Foundation asks DEA to better review process

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Epilepsy Foundation of US has called on the Drug Enforcement Administration (DEA), US, to revise its process for reviewing new treatments, which currently lack innovation and tra...Read more

Fight against TB needs $1.6 bn funding annually

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2013

Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at l...Read more

Daiichi to aid drug discovery projects

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery project for 2013. The company will select research partners for the proj...Read more

Queensland to get a new drug development center

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2015

Singapore: At the recent international BIO Conference in Philadelphia, Queensland's Premier Ms Annastacia Palaszczuk announced the establishment of the University of Queensland Emory Drug D...Read more

FDA follows EU, declares Patrys drug as 'orphan'

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: Australia-based Patrys, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal Product Designation for its lead anti-cancer product PAT-SM6, from t...Read more

AbbVie, Galapagos to make drugs for cystic fibrosis mutations

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

Singapore: Europe-based Galapagos and AbbVie entered into a global alliance to discover, develop and commercialize novel potentiator and combination therapies in cystic fibrosis (CF), an in...Read more

Mylan to produce generic of Gilead's HIV drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top this agreement, Mylan licensed the rights to produce and market generic ...Read more

MNCs bet on China to tide over patent cliff

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

Even as most emerging economies in Asia Pacific are trying to grab a foothold in the global biopharma space, China has etched an important spot for itself in that space in recent times. In ...Read more

Anaphore changes corporate name to RuiYi

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

Singapore: Anaphore changed its corporate name to RuiYi. As part of the company's shift in strategy to the R&D of novel biologic therapies in China, including monoclonal antibodies tha...Read more

Phylogica gets $400K grant to boost drug discovery

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

Singapore: Australia's peptide drug discovery company, Phylogica has received linkage grant from Australian Research Council (ARC) to collaborate with scientists at University of Queensland...Read more

Daiichi gets positive results in prasugrel trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial comparing efficacy and safety of prasugrel hydrochloride 20 mg loading...Read more

AstraZeneca acquires Pearl Therapeutics

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2013

Singapore: AstraZeneca has completed its acquisition of Pearl Therapeutics, a privately held company based in Redwood City, California, focused on the development of inhaled small-molecule ...Read more

Target for potent first-strike influenza drugs identified

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

Singapore: Scientists at St. Jude Children's Research Hospital have reported details of how certain drugs can precisely target and inhibit an enzyme essential for the influenza virus replic...Read more

TaiGen gets TFDA nod for bacterial pneumonia drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2014

Singapore: Taiwan based TaiGen Biotechnology has recieved Taiwan Food and Drug Administration (TFDA) approval for new drug application (NDA) of Taigexyn (nemonoxacin) oral formulation (500 ...Read more

Bionomics to raise $16.4 mn for Alzheimer's R&D

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Mar, 2013

Singapore: Bionomics plans to raise up to approximately $16.4 million of funds to advance development programs across drug pipeline, including BNC375, Bionomics' drug candidate for the tre...Read more

Advinus gets $36 mn research funding from Takeda

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year discovery collaboration. Under the terms of the agreement, Takeda will...Read more

Aslan gastric cancer phase II study shows +ve results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2013

Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule pan-HER inhibitor, in gastric cancer. Aslan001 reduced cell prolifer...Read more

Sanofi, Regeneron cancer drug Zaltrap gets EU nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltrap 25mg/ml concentrate in the European Union. Zaltrap 25mg/ml solutio...Read more